(Q39656538)

13 September 2017

1 reference

title

Forms of nephrotic syndrome more likely to progress to renal impairment (English)

1 reference

13 September 2017

1 reference

Chesney RW

1

1 reference

PubMed ID

3295719

13 September 2017

Novello AC

series ordinal

2

1 reference

13 September 2017

1 June 1987

1 reference

Pediatric Clinics of North America

13 September 2017

1 reference

13 September 2017

34

1 reference

13 September 2017

3

1 reference

13 September 2017

609-627

1 reference

Childhood nephrotic syndrome associated with diffuse mesangial hypercellularity. A report of the Southwest Pediatric Nephrology Study Group

13 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

The clinicopathologic meaning of the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Immune deposits and mesangial hypercellularity in minimal change nephrotic syndrome: clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Hemodynamically mediated glomerular injury and the progressive nature of kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Pathogenesis and treatment of membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

A controlled study of short-term prednisone treatment in adults with membranous nephropathy. Collaborative Study of the Adult Idiopathic Nephrotic Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Heterogeneity of nephritic factor and its identification as an immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Demonstration of C3d deposits in membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Treatment of idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Focal glomerular sclerosis in nephrotic patients: An electron microscopic study of glomerular podocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Extramembranous glomerulonephritis in children: report of 50 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Editorial: Focal glomerular sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Chronic glomerulonephritis associated with low serum complement activity (chronic hypocomplementemic glomerulonephritis)

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Idiopathic membranoproliferative glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Long-term outcome of primary nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Idiopathic membranous glomerulopathy in Canadian children: a clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Extramembranous glomerulonephritis in childhood: Relationship to systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Cell-Mediated Immunity in Idiopathic Membranous Nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Mesangiocapillary glomerulonephritis: Changes in glomerular morphology with long-term alternate-day prednisone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Nephrotic Syndrome with Mesangial-cell Proliferation in Children—A Distinct Entity?

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Idiopathic membranous nephropathy in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Long-Term Assessment of Chlorambucil in Children with Nephrotic Syndrome Who Fail to Respond Adequately to Corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Immunosuppressive Therapy in Primary Glomerulonephritis (Pros)

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Controlled Trial of Methylprednisolone and Chlorambucil in Idiopathic Membranous Nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Idiopathic membranous nephropathy in children

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

1 reference

7 January 2021

Serum C'3 lytic system in patients with glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Membranous nephropathy: response to steroids and immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Strong association of idiopathic membranous nephropathy with HLA-DR2 and MT1 in Japanese

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Membranous nephropathy: predictors of terminal renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Membranous glomerulonephritis in renal transplant. A case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Childhood membranoproliferative glomerulonephritis: an approach to management

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Clinicopathological study of nephrotic syndrome in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Prospective trial of warfarin and dipyridamole in patients with membranoproliferative glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

Recurrent membranoproliferative glomerulonephritis with glomerular properdin deposition in allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936253-8

7 January 2021

10.1016/S0031-3955(16)36253-8

Identifiers

DOI

0 references

PubMed ID

3295719

1 reference

PubMed ID

3295719